Martin-Nizard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Martin-Nizard has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Abdelmejid Kandoussi
Departement de Recherche sur les Lipoprotéines et l'Athérosclérose, INSERM UR 545, Institut Pasteur et Faculté de Pharmacie, Université de Lille 2 , Lille
1 shared publicationFrançois Bailleul
Laboratoire de Pharmacognosie, EA 1043, Faculté de Pharmacie, Université de Lille 2 , Lille
1 shared publicationJean-Charles Fruchart
Departement de Recherche sur les Lipoprotéines et l'Athérosclérose, INSERM UR 545, Institut Pasteur et Faculté de Pharmacie, Université de Lille 2 , Lille
1 shared publicationMarie Carpentier
Laboratoire de Pharmacognosie, EA 1043, Faculté de Pharmacie, Université de Lille 2 , Lille
1 shared publication- Patrick Duriez
Degenerative and Vascular Disorders, Faculty of Medicine, Univ. Lille, F-59000 Lille, France
1 shared publication - Sevser Sahpaz
University of Lille, INRAE, Liège, UPJV, JUNIA, Artois, Littoral Côte d’Opale,UMR Transfrontalière BioEcoAgro,Villeneuve-d'Ascq,France, France
1 shared publication
Latest Publications
- Open Access
- 1 December 2004
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 56 (12) , 1607-1611
Natural phenylpropanoids inhibit lipoprotein-induced endothelin-1 secretion by endothelial cells
There is increasing evidence that oxidized low-density lipoproteins (Ox-LDL) might be involved in the pathogenesis of atherosclerosis and it has been reported that polyphenols inhibit LDL peroxidation and atherosclerosis. Endothelin-1 (ET-1) is a potent vasoconstrictor peptide isolated from endothelial cells and it induces smooth muscle cell proliferation. ET-1 secretion is increased in atheroma and induces deleterious effects such as vasospasm and atherosclerosis. The goal of this study was to test the effect of four natural phenolic compounds against copper-oxidized LDL (Cu-LDL)-induced ET-1 liberation by bovine aortic endothelial cells (BAEC). The tested compounds were phenylpropanoid glycosides previously isolated from the aerial parts of Marrubium vulgare L. (acteoside 1, forsythoside B 2, arenarioside 3 and ballotetroside 4). ET-1 secretion increased when cells were incubated with Cu-LDL but the compounds 1–4 inhibited this increase. These results were confirmed by quantitative-polymerase chain reaction (QPCR) analysis. Since ET-1 plays an important role in atherosclerosis development, our work suggests that the tested phenylpropanoids could have a beneficial effect in inhibiting atherosclerosis development.
- 1 December 2004
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 56 (12) , 1607-1611
Open AccessNatural phenylpropanoids inhibit lipoprotein-induced endothelin-1 secretion by endothelial cells
There is increasing evidence that oxidized low-density lipoproteins (Ox-LDL) might be involved in the pathogenesis of atherosclerosis and it has been reported that polyphenols inhibit LDL peroxidation and atherosclerosis. Endothelin-1 (ET-1) is a potent vasoconstrictor peptide isolated from endothelial cells and it induces smooth muscle cell proliferation. ET-1 secretion is increased in atheroma and induces deleterious effects such as vasospasm and atherosclerosis. The goal of this study was to test the effect of four natural phenolic compounds against copper-oxidized LDL (Cu-LDL)-induced ET-1 liberation by bovine aortic endothelial cells (BAEC). The tested compounds were phenylpropanoid glycosides previously isolated from the aerial parts of Marrubium vulgare L. (acteoside 1, forsythoside B 2, arenarioside 3 and ballotetroside 4). ET-1 secretion increased when cells were incubated with Cu-LDL but the compounds 1–4 inhibited this increase. These results were confirmed by quantitative-polymerase chain reaction (QPCR) analysis. Since ET-1 plays an important role in atherosclerosis development, our work suggests that the tested phenylpropanoids could have a beneficial effect in inhibiting atherosclerosis development.